Reports

Ideas That Generate Results

1. Analyst View

2. Research Methodology

3. India API Industry Outlook
    3.1 Top 5 API Markets of the World
    3.2 Share of India in Global API Market
    3.3 Indian API Market Size (2009-2014)
    3.4 Top 10 APIs in the Indian API Market

4. Drivers & Challenges
    4.1 Drivers
           4.1.1 Rising Healthcare Expenditure
           4.1.2 Increasing Disposable Incomes
           4.1.3 Rise in Geriatric Population
           4.1.4 Increasing Incidences of Chronic Diseases
           4.1.5 Patent Expiry of Blockbuster Drugs
           4.1.6 Increased Consumption of Generic Drugs
           4.1.7 Invention of New Generation of APIs
    4.2 Challenges
           4.2.1 Overdependence on China for Imports
           4.2.2 Complex License Renewal Procedure
           4.2.3 Few Manufacturers in the API Industry
           4.2.4 Inadequate Infrastructure Facilities
           4.2.5 Lack of Government Support
           4.2.6 Stringent Regulatory Policies

5. Market Segmentation
    5.1 By Type of Manufacturing
    5.2 By Type of Drug
    5.3 By Type of API
    5.4 By Type of Therapeutic Area

6. Mergers and Acquisitions

7. Government Initiatives
     7.1 Katoch Committee
     7.2 ‘Make in India’ Campaign
     7.3 Pharma Vision 2020
     7.4 Establishment of New NIPERs

8. Regulatory Scenario

9. Competitive Landscape
    9.1 Profiles
          9.1.1 Sun Pharma
          9.1.2 Cipla Limited
          9.1.3 Biocon
          9.1.4 Dr. Reddy’s Laboratories
          9.1.5 Lupin Ltd.
          9.1.6 Aurobindo Pharma Limited
          9.1.7 Wockhardt
          9.1.8 Zydus Cadila
          9.1.9 Glenmark
          9.1.10 Jubilant LifeSciences

10. Future Outlook

11. Opportunities and Recommendations